Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 15,160 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 15,160 shares of the stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the completion of the transaction, the chief executive officer now directly owns 215,494 shares of the company’s stock, valued at $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Amit Gupta also recently made the following trade(s):

  • On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total transaction of $21,887.88.

Cardlytics Stock Up 1.3 %

Shares of CDLX opened at $3.88 on Friday. The company has a market capitalization of $197.18 million, a price-to-earnings ratio of -0.64 and a beta of 1.53. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The stock’s 50-day moving average price is $3.66 and its 200-day moving average price is $4.39. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics (NASDAQ:CDLXGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The business’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.26) EPS. On average, sell-side analysts predict that Cardlytics, Inc. will post -1.52 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CDLX shares. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Finally, Evercore ISI initiated coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 target price for the company. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $6.92.

Read Our Latest Stock Analysis on CDLX

Institutional Trading of Cardlytics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its stake in shares of Cardlytics by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after acquiring an additional 5,392 shares in the last quarter. Tallon Kerry Patrick purchased a new position in Cardlytics during the fourth quarter worth approximately $37,000. Sanctuary Advisors LLC acquired a new stake in Cardlytics in the third quarter valued at approximately $82,000. Barclays PLC grew its holdings in Cardlytics by 223.9% in the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after buying an additional 73,484 shares in the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Recommended Stories

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.